Capital Flow Monitor · Sponsors · CIK 2088082
Electra Therapeutics, Inc.
230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080 · (888) 743-2290
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$184.1M
Sold
$134.2M
% sold
72.9%
Investors
19
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-30 | D ·current | 506(b) | $184.1M | $134.2M | 72.9% | 19 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Thomas Geninatti, Ph.D. — Director, SOUTH SAN FRANCISCO, CA
- Beth Seidenberg, M.D. — Director, SOUTH SAN FRANCISCO, CA
- Carl Gordon, Ph.D. — Director, SOUTH SAN FRANCISCO, CA
-
Matthew Fust — Director, SOUTH SAN FRANCISCO, CA
1 other raise
- Star Therapeutics LLC $125.0M of $125.0M · 100.0%
- Nancy Stagliano, Ph.D. — Director, SOUTH SAN FRANCISCO, CA
- Quehuong (Kathy) Dong, Pharm.D. — Executive Officer / Director, SOUTH SAN FRANCISCO, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.